Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 103

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 103
---
trading market for the Series A Warrants or the Pre-Funded Warrants, and we do not expect a market to develop. In addition, we do not
intend to apply to list the Series A Warrants or the Pre-Funded Warrants on any national securities exchange or other nationally recognized
trading system. Without an active market, the liquidity of the Series A Warrants and the Pre-Funded Warrants will be limited.

Except as otherwise set forth in Series A Warrants and Pre-Funded Warrants, holders of the Series A Warrants and Pre-Funded Warrants offered hereby will have no rights as shareholders with respect to the common shares underlying the Series A Warrants and Pre-Funded Warrants until such holders exercise their Series A Warrants and Pre-Funded Warrants and acquire our common shares.

Except as otherwise set forth
in the Series A Warrants and Pre-Funded Warrants, until holders of the Series A Warrants and Pre-Funded Warrants acquire our common shares
upon exercise thereof, such holders of the Series A Warrants and Pre-Funded Warrants will have no rights with respect to the common shares
underlying such warrants, such as voting rights. Upon exercise of the Series A Warrants or the Pre-Funded Warrants, as the case may be,
the holder will be entitled to exercise the rights of a shareholder only as to matters for which the record date occurs after

Future sales of our Common Stock could cause the market price for our Common Stock to further decline.

We cannot predict the effect,
if any, that market sales of shares of our Common Stock or the availability of shares of our Common Stock, including upon exercise or
conversion of any of our outstanding securities, for sale will have on the market price of our Common Stock prevailing from time to time.
Sales of substantial amounts of shares of our Common Stock on the public market, or the perception that those sales will occur, could
cause the market price of our Common Stock to decline or be depressed.

As described elsewhere herein,
we expect to issue additional securities imminently to raise capital to continue our operations. Additionally, we may issue our securities
if we need to raise capital in connection with capital expenditure, working capital requirement or acquisition. The number of shares
of our Common Stock issued in connection with a capital expenditure, working capital requirement or acquisition could constitute a material
portion of our then-outstanding shares of Common Stock. Any perceived excess in the supply of our shares in the market could negatively
impact our share